Hepatic Gene Expression Profile in Mice Perorally Infected with Echinococcus multilocularis Eggs Authors: Bruno Gottstein, Matthias Wittwer, Marc Schild, Michael Merli, Stephen L. Leib, Norbert Müller, Joachim Müller, Rolf Jaggi Published: 2010, PLOS ONE DOI: 10.1371/journal.pone.0009779 ABSTRACT Alveolar echinococcosis (AE) is a severe chronic hepatic parasitic disease currently emerging in central and eastern Europe. Untreated AE presents a high mortality (>90%) due to a severe hepatic destruction as a result of parasitic metacestode proliferation which behaves like a malignant tumor. Despite this severe course and outcome of disease, the genetic program that regulates the host response leading to organ damage as a consequence of hepatic alveolar echinococcosis is largely unknown. We used a mouse model of AE to assess gene expression profiles in the liver after establishment of a chronic disease status as a result of a primary peroral infection with eggs of the fox tapeworm Echinococcus multilocularis . Among 38 genes differentially regulated (false discovery rate adjusted p≤0.05), 35 genes were assigned to the functional gene ontology group , while 3 associated with the functional group . Upregulated genes associated with could be clustered into functional subgroups including , , , and . Two downregulated genes related to and , respectively. The genes either associated with an or an pathway. From the overexpressed genes, 18 genes were subsequently processed with a Custom Array microfluidic card system in order to assess respective expression status at the mRNA level relative to 5 reference genes (Gapdh, Est1, Rlp3, Mdh-1, Rpl37) selected upon a constitutive and stable expression level. The results generated by the two independent tools used for the assessment of gene expression, i.e., microarray and microfluidic card system, exhibited a high level of congruency (Spearman correlation rho = 0.81, p = 7.87e-5) and thus validated the applied methods. Based on this set of biomarkers, new diagnostic targets have been made available to predict disease status and progression. These biomarkers may also offer new targets for immuno-therapeutic intervention. INTRODUCTION Alveolar echinococcosis (AE) is a result of a hepatic infection with the larval (metacestode) stage of the fox tapeworm Echinococcus multilocularis . AE as a disease is associated with high mortality (>90%) if remaining untreated [1] . AE patients are affected by hepatic sequelae that are due to a wide spectrum of liver injury leading predominantly to cholestatic jaundice (about a third of cases) and/or unspecific epigastric pain (about a third of cases), together with various symptoms such as fatigue, weight loss and hepatomegaly [2] . As a result of peroral infection via eggs of E. multilocularis , the parasitic metacestode (larval stage) subsequently grows as a tumor-like tissue in the liver of its intermediate host, include predominantly small rodents, but accidentally also humans. Thus, the laboratory mouse is an excellent model to study the host-parasite interplay. While most studies so far have been carried out upon so-called secondary infections (intraperitoneal inoculation of fully developed metacestode tissue), the respective difficulty lies in the fact that this infection model does not include primary hepatic events that are crucial to understand the natural host-parasite interplay. The real approach to determining the biological events in vivo is to carry out peroral inoculation of infectious E. multilocularis eggs, experiments that can only be performed in appropriate biosafety level 3 laboratory units. Such experimental infection is referred to as primary infection, resulting in an intrahepatic tumor-like growth of the metacestode that overcomes the immune system and subsequently establishes a chronic phase of infection, which persists approximately between 4–6 months p.i.. Through effects on cells of both the innate and adaptive arms of the immune response, the parasite can orchestrate a range of outcomes that are beneficial not only for metacestode establishment, but also in terms of facilitating its proliferation and maturation. In addition, the complex host-parasite interaction leads to only limited pathology. Likewise, a higher survival potential for both host and parasite is achieved. Despite the severity of AE in humans, the genetic program that regulates the mechanisms leading to liver damage as a consequence of AE is largely unknown. High-throughput methods, e.g. DNA microarrays, can provide a comprehensive picture of the genes underlying the host responses to AE. This knowledge is a prerequisite for understanding the pathogenesis of liver damage and can drive the development of new prognostic and/or therapeutic modalities for AE. The aim of this study was to identify genes and sets of genes implicated in the immuno-pathophysiological mechanisms leading to the induction of a host response to infection, but subsequently also to hepatic damage observed in experimental AE. We used an appropriate mouse model of primary AE infection and DNA microarray technology to assess gene expression profiles in the periparasitic liver tissue known to be preferentially affected, in mock-infected controls and during the phase of early chronic AE following peroral infection of the mice with infectious E. multilocularis eggs (thus exactly mimicking the natural way of infection). Significantly overexpressed genes on microarrays were re-investigated and validated by real-time RT-PCR using microfluidic cards. RESULTS Eight to 10-week-old female BALB/c mice were purchased from Charles River GmbH, Germany. For all experiments, animals were matched for age and weight. All mice were housed and handled under standard aseptic animal laboratory conditions according to the rules of the Swiss regulations for animal experimentation. Maintenance of perorally E. multilocularis egg infected animals (see below) was carried out in a B3 safety containment, these experiments required governmental safety approval (Swiss Federal concession no. A990006/3A). Primary infections of mice were all based upon the use of a single batch of E. multilocularis eggs, obtained and purified as previously described [3] . The viability and infectivity rate of this batch of eggs had been predetermined by appropriate explorative titration-infection trials in mice [4] . For the present batch and experiments, primary infection parameters were 2,000 eggs per mouse to be administered perorally, yielding a medium number of 26 primary lesions per liver (range 12–35). Technically, intragastric E. multilocularis egg inoculation was performed as described elsewhere [5] . 31 days after infection, all infected animals (n = 8) had alveolar echinococcosis of the liver as evidenced by the presence of between 5 to 22 hepatic liver lesions, all exhibiting the same morphology including a central parasitic vesicle of approximately 1–2 mm of diameter, and surrounded by a white periparasitic inflammatory corona of about 0.5 mm in diameter. Mock-infected control animals presented neither macroscopically nor microscopically visible lesions in the liver. MICROARRAYS Changes of the mouse hepatic gene expression in response to primary hepatic E. multilocularis infection were examined during the initial phase of chronic infection stage (i.e. after 1 month). The parasitized animals shared a total of 38 genes that significantly changed after 1 mon of infection (fdr adjusted P-value of <0.05) ( Tab. 1 ). Of those genes, 36 appeared upregulated in reference to non-infected controls, and 2 yielded down-regulation. In bold (AFFY ID nos.) are genes that subsequently were subjected to retesting by a microfluidic card system. Genes were selected upon  =  Avg Diff change factor >2.0, and/or p>0.05 for pairwise comparisons with mock-infected liver tissue. TABLE: Probe-sets representing 38 genes, their expression levels in the liver, organized according to their functional groups. # AFFY ID REFSEQ ID GENE NCBI Gene ID DESCR ratio expr_AE-LIVER expr_LIVER mock-infected OVEREXPESSED/UPREGULATED Immune response/defense [functional group]: Macrophages (MØ) 01 1425394_at XP_001471630 BC023105 667597 cDNA sequence aBC023105 p47-like GTPase 10 17 169 02 1449009_at NM_011579 Tgtp 21822 T-cell specific GTPase 6.6 302 2001 03 1429184_at NM_001039160 Gvin1 74558 GTPase, very large interferon inducible 1 3.3 293 954 04 1424923_at NM_009251 Serpina3g 20715 serine (or cysteine) peptidase inhibitor, member 3G 6.4 84 534 05 1420549_at NM_010259 Gbp1 14468 guanylate binding protein 1 5.0 24 118 06 1435906_x_at NM_010260 Gbp2 14469 guanylate binding protein 2 3.0 93 277 07 1418776_at NM_029509 5830443L24Rik 76074 RIKEN cDNA 5830443L24 gene, GBP-like 3.4 91 310 08 1449498_at NM_010766 Marco 17167 macrophage receptor with collagenous structure 4.7 51 236 09 1447927_at NM_194336 Mpa2l 100702 macrophage activation 2 like 3.6 342 1223 10 1440481_at NM_009283 Stat1 20846 signal transducer and activator of transcription 1 3.4 36 121 11 1436808_x_at NM_008566 Mcm5 17218 minichromosome maintenance deficient 5, 2.9 31 91 12 1420699_at NM_020008 Clec7a 56644 C-type lectin domain family 7, member a 2.8 70 193 13 1416295_a_at NM_013563 Il2rg 16186 interleukin 2 receptor, gamma chain 2.8 67 189 14 1426808_at NM_010705 Lgals3 16854 lectin, galactose binding, soluble 3, galektin 2.6 118 300 15 1448748_at NM_019549 Plek 56193 pleckstrin 2.4 29 70 Immune response/defense [functional group]: APC 16 1450648_s_at NM_207105 H2-Ab1 14961 histocompatibility 2, class II antigen A, beta 1 5.6 230 1287 17 1417025_at NM_010382 H2-Eb1 14969 histocompatibility 2, class II antigen E beta 5.3 151 796 18 1435290_x_at NM_010378 H2-Aa 14960 histocompatibility 2, class II antigen A, alpha 4.4 457 1999 19 1422527_at NM_010386 H2-Dma 14998 histocompatibility 2, class II, locus Dma 2.9 31 90 20 1418638_at NM_010387 H2-DMb1 14999 histocompatibility 2, class II, locus Mb1 2.9 15 43 21 1425519_a_at NM_001042605 Cd74 16149 CD74 antigen (invariant polypeptide of major histo compatibility complex, class II antigen-associated) 3.8 602 2268 Immune response/defense [functional group]: Lymphocytes, chemokines and regulation 22 1418652_at NM_008599 Cxcl9 17329 chemokine (C-X-C motif) ligand 9 5.2 254 1328 23 1418126_at NM_207105 Ccl5 20304 chemokine (C-C motif) ligand 5 4.5 24 111 24 1418930_at NM_021274 Cxcl10 15945 chemokine (C-X-C motif) ligand 10 4.1 81 327 25 1423467_at NM_021718 Ms4a4b 60361 membrane-spanning 4-domains, subfamily A, CD20 3.0 25 74 26 1424638_at NM_001111099 Cdkn1a 12575 cyclin-dependent kinase inhibitor 1A (P21) 2.8 22 63 27 1452349_x_at NM_172648 Ifi205 226695 interferon activated gene 205 2.6 188 492 28 1422903_at NM_010745 Ly86 17084 lymphocyte antigen 86 2.4 211 506 29 1421855_at NM_008013 Fgl2 14190 fibrinogen-like protein 2 2.4 37 88 30 1448162_at NM_011693 Vcam1 22329 vascular cell adhesion molecule 1 2.2 118 259 31 1447830_s_at NM_009061 Rgs2 19735 regulator of G-protein signaling 2 2.3 29 67 Immune response/defense [functional group]: B-cells 32 1427455_x_at XM_001476664 Igk-V1 16081 immunoglobulin kappa chain variable 1 (V1) 4.7 90 420 33 1452417_x_a XM_001476664 Igk-C 16071 immunoglobulin kappa chain, constant region 4.4 130 574 Immune response/defense [functional group]: Eosinophils 34 1449846_at NM_007895 Ear2 13587 eosinophil-associated, ribonuclease A family, member 2 2.6 41 104 Intermediary metabolism [functional group]: hepatocytes 35 1431056_a_at NM_008509 Lpl 16956 lipoprotein lipase 2.6 358 975 36 1442798_x_at NM_001033245 Hk3 212032 hexokinase 3 2.4 37 90 DOWNREGULATED Immune response/defense [functional group]: Lymphocytes, chemokines and regulation 37 1451069_at NM_145478 Pim3 223775 proviral integration site 3 0.4 298 118 Intermediary metabolism [functional group]: hepatocytes 38 1451588_at NM_026947 1810022C23Rik 69123 RIKEN cDNA 1810022C23 gene, Crotonase-like 0.4 278 100 MICROFLUIDIC CARD SYSTEM MRNA ASSESSMENT From the overexpressed genes, 18 genes were subsequently investigated with a TaqMan® Custom Array microfluidic card system in order to assess respective expression status at the mRNA level in reference to 5 reference genes (Gapdh, Est1, Rlp3, Mdh-1, Rpl37). In Table 2 , up- and downregulation were calculated from real time data, genes were clustered according to the mode used for Table 1 . Values correspond to mean of 5 infected animals (inf.) or 3 non-infected control animals (contr.). When comparing microarray and microfluidic card system, they exhibited a high level of congruency (Spearman correlation rho = 0.81, p = 7.87e-5). TABLE: TaqMan® Custom Array microfluidic card system was used to assess expression status at the mRNA level of 18 selected genes (see Table 1 ) in reference to 5 reference genes (Gapdh, Est1, Rlp3, Mdh-1, Rpl37). # REFSEQ ID GENE Gapdh contr./inf. Est1 contr./inf. Rpl23 contr./inf. Mdh-1 contr./inf. Rpl-37 contr./inf. OVEREXPESSED/UPREGULATED Immune response/defense [functional group]: Macrophages (MØ) 02 NM_011579 Tgtp 9.7 8.2 8.8 11.1 10.7 08 NM_010766 Marco 6.3 5.1 5.6 7.0 6.8 12 NM_020008 Clec7a 4.0 3.3 3.7 4.5 4.4 13 NM_013563 Il2rg 3.7 3.2 3.5 4.2 4.2 14 NM_010705 Lgals3 3.5 3.0 3.3 4.1 3.9 10 NM_009283 Stat1 2.9 2.5 2.7 3.3 3.4 Immune response/defense [functional group]: APC 17 NM_011579 H2-Eb1 (Ab1) 6.8 5.9 6.3 7.8 7.5 19 NM_010386 H2-Dma (H2aa) 5.9 5.0 5.4 6.7 6.4 20 NM_010387 H2-DMb1 (H2-Eb1) 6.3 5.3 5.7 7.1 6.7 21 NM_001042605 Cd74 5.7 4.9 5.3 6.6 6.2 Immune response/defense [functional group]: APC 22 NM_008599 Cxcl9 6.5 5.5 5.6 7.3 7.0 23 NM_207105 Ccl5 6.0 5.1 5.9 7.0 6.8 24 NM_021274 Cxcl10 6.2 5.0 5.0 6.9 6.2 25 NM_021718 Ms4a4b 4.8 3.8 4.2 5.3 5.2 29 NM_008013 Fgl2 3.4 2.8 3.1 3.8 3.7 28 NM_010745 Ly86 3.3 2.6 2.8 3.6 3.4 30 NM_011693 Vcam1 3.0 2.6 2.9 3.5 3.5 Intermediary metabolism [functional group]: hepatocytes 35 NM_008509 Lpl 3.5 2.9 3.5 4.0 4.0 CONTROLS 18s 1.5 1.1 1.2 1.6 1.5 standards Gapdh 1.0 1.6 1.7 1.7 1.7 Est1 2.0 1.0 1.8 2.2 2.3 Rlp23 1.7 1.4 1.0 1.9 2.0 Mdh-1 1.5 1.2 1.3 1.0 1.7 Rpl37 1.5 1.3 1.4 1.7 1.0 OVERVIEW OF DIFFERENTIAL GENE REGULATION Most (34 from 36, 94%) of upregulated genes were annotated to processes, while 2 genes (6%) were annotated to of hepatocytes. Upregulated genes associated with (n = 34) could be clustered into functional subgroups including (n = 15), (n = 6), (n = 10), (n = 2) and (n = 1). Two downregulated genes related to and , respectively ( Tab. 1 ). The genes (n = 35) either associated with an or an pathway, are schematically drawn in ( Fig. 1 ). Interaction of cell types in mouse livers infected with E. multilocularis metacestodes as suggested by the pattern of differentially expressed genes (numbers in brackets) shown in Table 1 . Interactions indicated by dashed arrows are hypothetical. In the following paragraph, first upregulated, then downregulated genes will be presented more in details: IMMUNE RESPONSE/DEFENSE [MØ]; UP-REGULATED These belong to the interferon-inducible p47 GTPases. Interferons (with a preference IFN-γ over α/β) bind to their respective receptors. For Tgtp, the binding is followed by phosphorylation of STAT1 and rapid translocation of P-STAT1 dimers to the nucleus. There, the complex activates transcription of p47 GTPases by binding to the IFN-γ activation site (GAS) in the promoter. The gene products enable the MØ phagosome to be part of the innate defense of cells to infection, but its role in such defense has not yet been clearly defined [6] . GBPS (GBP1, GBP2, 5830443L24RIK, GBP8) GBPs are upregulated in macrophages in response to IFN-γ. GBP-1 is a large GTPase that is induced by inflammatory cytokines and acts antiangiogenically through the inhibition of endothelial cell proliferation and migration [7] . Interestingly, some GBPs are upregulated in mice infected with intracellular pathogens such as L. monocytogenes and T. gondii and are colocalized with T. gondii in infected cells [8] . GBP-1 is also a marker of inflammation that may protect against epithelial apoptosis induced by inflammatory cytokines and subsequent loss of barrier function [9] . MARCO MØ express several host-defense receptors that can be divided into two classes; those dependent on opsonizing components for recognizing pathogens, and those that can recognize pathogens directly. MARCO belongs to a family of class A scavenger with pattern recognition receptors, some of which have been shown to bind lipopolysaccharide that are surface components of many infectious organisms [10] . It will be of upmost interest to search for E. multilocularis glycans such as Em492 for their interaction potential with MØ via MARCO. STAT1 STAT1 plays an important role in HA-mediated inflammatory processes [11] . It has been demonstrated that IL-27 controls the development of Th17 and iTreg cells via differential effects on STAT1 [12] . One of the main role of STAT1 is in activating GBP2 transcription to provide transcriptionally competent chromatin [13] . Activation of STAT1 attenuates liver fibrosis through inhibition of HSC proliferation, attenuation of TGF-beta signaling, and stimulation of NK cell killing of activated HSCs. STAT1 could be a new therapeutic target for treating alveolar echinococcosis, similar to that shown e.g. for liver fibrosis [14] . Analysis of T cell responses revealed that STAT1 was not required for the development of a Th1 response, but was required for the infection-induced up-regulation of T-bet. Moreover, Stat1 interacts with Mcm5 and thus may trigger IFN-dependent cell proliferation [15] . MCM5 (CD46) Mcm5 is a member of the MCM complex which is essential for the initiation of replication. Mcm5 is one of the nuclear proteins that inertact with phosphorylated STAT1 and therefore may play a role in JAK-STAT-modulated cell proliferation [15] . Like other replication factors, Mcm5 is considered as a marker for tumor proliferation, thus it will be interesting to study its putative role in promoting the unrestricted metacestode proliferation encountered in murine alveolar echinococcosis of the liver. IL2RG (CD132), PLECKSTRIN, LGALS3 Naive T cells can be induced to undergo homeostatic proliferation of variable speed with a few members of the common gamma-chain (CD132) family of cytokines [16] . The IL2 receptor γ chain interacts with insulin receptor substrate (IRS) proteins. These proteins have a pleckstrin binding domain and are phosphorylated partly by JAK-kinases [17] . Pleckstrin is involved in intracellular signaling, e.g. by PI3K pathways that participate in IL-signalling [17] , insulin signaling and inflammatory responses [18] . Galectin-3 is a 30 kDa lectin binding β-galactoside expressed and secreted by macrophages. It is a chemoattractant for monocytes and macrophages. CD98 is the receptor for galectin on the macrophage membrane and triggers macrophage activation by the PI3K-pathway. Both components are involved in alternative macrophage activation by IL-4 since disruption of the galectin gene in mice restrains macrophage activation [19] . CLEC7A The c-type lectin 7a (Dectin-1) is expressed on monocytes, macrophages, and dendritic cells as a phagocytic receptor for β-glucan containing particles. Dectin-1 collaborates with toll-like receptor 2 in inflammatory responses against microbial pathogens [20] . SERPINA3G Serpin3g is a cytoplasmic inhibitor of papain-like, and is required for the protection of cells from caspase-independent PCD triggered by tumor necrosis factor-alpha. In the absence of caspase activity, Spi2A suppressed PCD by inhibiting cathepsin B after it was released into the cytoplasm. Spi2A also directly protects against ROS-mediated PCD, which is consistent with a role in suppressing caspase-independent pathways of PCD. Inhibition of lysosomal executioner proteases by Spi2A is a physiological mechanism by which cells are protected from caspase-independent programmed cell death [21] . IMMUNE RESPONSE/DEFENSE [APC]; UP-REGULATED Activation of naive CD4 T cells by dendritic cells requires the sequential interaction of many TCR molecules with peptide-class II complexes of the appropriate specificity. Such interaction results in morphological transformation of class II MHC-containing endosomal compartments. It is generally accepted that MHC II alleles may influence T-cell functions by restricting TCR access to specific residues of the I-A-bound peptide. Thus, this is of significance to diseases that display genetic linkage to specific MHC II alleles, which, however, has not yet been demonstrated for neither murine nor human alveolar echinococcosis. CD74 Dendritic cells (DCs) sample peripheral tissues of the body in search of antigens to present to T cells. This requires two processes, antigen processing and cell motility, originally thought to occur independently. The major histocompatibility complex II-associated invariant chain (Ii or CD74), a known regulator of antigen processing, negatively regulates DC motility in vivo [22] . IMMUNE RESPONSE/DEFENSE [LYMPHOCYTES, CHEMOKINES AND REGULATION]; UP-REGULATED CXCL9 is a proinflammatory monokine, induced by interferon-gamma, which supports Th1-cell mediated tissue inflammation [23] . CXCL10 regulates liver innate immune response [24] , its role in alveolar echinococcosis is still unknown. It is generally accepted to potentiate the gene expression of iNOS and CXC chemokine ligand 10 (CXCL10), a major chemoattractant of T helper cell type 1 [25] . This protein is also expressed as a marker of hepatic inflammation and injury, suggesting a role in liver repair and regeneration [26] . CCL5 (RANTES) CCL5 expression correlates with resistance, and blockade of CCL5 rendered mice more susceptible to infection. CCL5 is part of the cascade of events leading to efficient parasite control such as in L. major infection. CCL5 up-regulates IL-12, IFN-gamma, and migration of Th1 cells, particularly memory T cells [27] . MS4A4B MS4a4B was reported to be expressed in Th1-cells but not Th2-cells. Overexpression of MS4a4B in primary CD4+ T-cell blasts enhanced T-cell receptor (TCR)-induced Th1 cytokine production. This suggested that MS4a4B expression is tightly regulated during T-cell development and that MS4a4B expression promotes Th1 function and/or differentiation [28] . CDKN1A (P21) P21 plays an essential role in determining the type of cell death, positively for apoptosis and negatively for autophagy [29] . Genetic inactivation of p21 in JNK1−/− mice restored hepatocyte proliferation in models of both liver carcinogenesis and liver regeneration, and overexpression of c-Myc increased proliferation of JNK1−/− liver cells. Pharmacologic inhibition of JNK reduced the growth of both xenografted human HCC cells and chemically induced mouse liver cancers. These findings provide a mechanistic link between JNK activity and liver cell proliferation via p21 and c-Myc and suggest JNK targeting can be considered as a new therapeutic approach for HCC treatment. [30] . IFI205 Ifi205 belongs to the class of interferon inducible p200 proteins that regulate cell proliferation. Ifi205 has been shown to upregulate the cell cycle inhibitor P21 by interacting with p53 [31] . LY86 (MD1) Ly86 contributed to LPS-induced B-cell proliferation, antibody production, and B7.2/CD86 up-regulation [32] . FGL2 FGL2 inhibits dendritic cell maturation and induces apoptosis of B cells through binding to the low-affinity FcgammaRIIB receptor, and thus contributes to Treg cell activity [33] . There is evidence FGL2 exerts immunosuppressive effects on T cell proliferation and DC maturation [34] . VCAM-1 Vascular cell adhesion molecule-1 (VCAM-1) mediates cell adhesion and transendothelial migration of leukocytes. These molecules do not play a direct role in the recruitment of leukocytes to the infected liver, but instead contribute to IL-12p40-production by splenic CD8(+) dendritic cells (DC). This can be associated with reduced anti-parasitic CD4(+) T cell activation in the spleen and lowered hepatic IFN-gamma, TNF and nitric oxide production. Such effects can be associated with enhanced parasite growth in the liver [35] . RGS2 (29) Rgs (regulator of G protein signaling) proteins have been characterized as inhibitors of signal transduction cascades initiated by G-protein coupled receptors. Rgs2 is widely expressed in mouse and human tissues. Knock-down studies have shown that Rgs2 is important for T-cell-proliferation and interleukin production [36] . IMMUNE RESPONSE/DEFENSE [EOSINOPHILS]; UP-REGULATED Based on its ability to serve as a chemoattractant and activator of DCs, as well as the capacity to enhance antigen-specific immune responses, Ear2 (eosinophil-associated ribonuclease 4) is considered to have the properties of an endogenous alarmin that alerts the adaptive immune system for preferential enhancement of antigen-specific Th2 immune responses [37] . Furthermore, anti-microbial actiovities have been documented by Nakajima et al. [38] . Mouse EAR2, is also chemotactic for human as well as mouse DCs [39] . INTERMEDIARY METABOLISM [HEPATOCYTES]; UP-REGULATED Lipoprotein lipase (Lpl) binds to lipoproteins and specific cell surface proteins in a non-catalytic way. Lpl is expressed in a tissue-specific pattern during development with an increase in adipose tissue, but a decrease in liver. Interestingly, Lpl is also expressed in macrophages where interleukins and interferons downregulate and free fatty acids upregulate expression [40] . Conclusively, an increase would suggest the differentiation of adipocytes in the infected liver. HK3 Hexokinase III has a very high affinity for glucose, is inhibited by glucose at higher concentrations. Given the specific catalytic patterns, hexokinase III is most likely involved in anabolic processes, e.g. lipid biosynthesis, by providing NADPH by the pentose phosphate pathway [41] . IMMUNE RESPONSE/DEFENSE [LYMPHOCYTES, CHEMOKINES AND REGULATION]; DOWN-REGULATED Pim3 is expressed at low levels in the liver, but upregulated in malignant liver tissue [42] . Pim 3 phosphorylates and thus inactivates the pro-apoptotic protein Bad. The active Bad protein binds to anti-apoptotic proteins of the Bcl2 family thus allowing induction. By phosphorylation of Bad, binding sites for 14-3-3-protein are created. The resulting Bad-14-3-3-complex is no longer able to interfere with Bcl2 proteins thus preventing cell death [43] . INTERMEDIARY METABOLISM [HEPATOCYTES]; DOWN-REGULATED Crotonase (Enoyl-coenzyme-A-hydratase) catalyses the hydratation of trans-2-enoyl-CoA thioesters resulting from the first step of beta-oxidation of fatty acids [44] . DISCUSSION The involvement of cellular immunity in controlling the infection is strongly suggested by the intense granulomatous infiltration observed in the periparasitic area of lesions in experimentally infected mice [45] , [46] . Immunodeficient athymic nude [47] and SCID mice [48] as well as HIV-co-infected patients [49] , [50] exhibited high susceptibility to infection and disease, thus suggesting that the host cell mediated immune response plays an important role in suppressing the larval growth. E. multilocularis appears to induce skewed Th2-responses [46] . Based on in vitro and in vivo studies, Th2-dominated immunity was associated with increased susceptibility to disease, while Th1 cell activation through IL-12 [46] , IFNγ [51] , [52] , TNFα [53] and IFNα [54] was suggested to induce protective immunity in AE [55] , [56] . Innate mechanisms appeared also to resistance upon attack by cytotoxic compounds such as activated complement proteins and NO, associated to increased macrophage activities [57] , [58] . With regard to the hepatic gene expression profiles of our study related to immunostimulatory pathways (thus potentially also to efficient host control mechanisms), most of the highest expressed molecules (BC023105, Tgtp, Gvin1, GBPs, Clec7a) appear to localize within cytokine pathways involved in direct or indirect MØ activities. Respective parasite cell damage may be one option, but also subsequent antigen processing (MARCO: carbohydrates? Ly86: LPS-like antigens?) and orchestration of the subsequent T cell orientation (STAT1, Mcm5, Il2rg, Pleckstrin, Lgals3). Beside MØ, dendritic cells may intrahepatically contribute to the immunological response and defense, as indicated by hyperexpressed partner cell (e.g. CD4 T cells) molecules such as H2-Ab1, H2-Eb1, H2-aa, H2-Dma, H2-DMb1, CD74 and CCL5, all associated to CD4 T cell activation and action, especially Th1 (CCL5, Ms4a4b, Rgs2). That all these events are accompanied by periparasitic inflammatory processes are supported by overexpressed CXCL9, CXCL10. Finally, another hyperexpressed molecule (Serpina3g) may synergistically contribute to parasitocidal host effector mechanisms by controlling immunopathological events related to apoptotic tissue damage, putatively triggered by Cdkn1a, and downregulated Pim3 may contribute to such a phenomenon as well. To carry out a more profound interpretation of the present findings, we have to take into account that the time point of investigation (infection status) corresponds to a rather early stage, not yet switched into the late/chronic stage of AE. Globally, the above listed phenomena correspond mostly to a still Th1-oriented immune response, which may putatively be the correct way to control infection. We know, however, that the parasite survives in the host. By inducing functional changes in DCs and MØs, the metacestode can achieve important shifts in T-cell subsets. The initial acute inflammatory Th1 response is subverted gradually to a Th2 response during the chronic phase of AE [59] . Cytokines, such as IL-4, IL-5, IL-9 and IL-13, secreted largely by immune-cell types in response to parasite antigens, not only down-modulate the Th1 response but can also promote parasite expulsion and tissue renewal and repair [60] . The metacestode most likely achieves the late infection stage Th2 expansion through the induction of regulatory cytokines, such as IL-10 and TGF-β [59] . To provide a platform of understanding the late stage event, we will have to prompt a more detailed investigation by using late stage infection mice. The question will arise as to whether it will be possible to obtain appropriate hepatic tissue free of metacestode material (a prerequisite in the present study), as at the advanced/late stage, usually the whole liver is metastatically interspersed with parasite cells/vesicles. One of the key questions remaining is how during the infection course the initial Th1-orientation switches to a rather Th2-oriented pathway. Our interest will thus focus on unraveling the metacestode tools (metabolites) that could trigger such a re-orientation. FUNCTIONAL ANALYSIS, IMMUNOSUPPRESSIVE PATHWAY An interesting feature observed in chronic AE is a marked depression of the cell-mediated immune response [61] , [62] , [63] . These general characteristics of E. multilocularis , including the seemingly tumor like growth, its ability to modulate host immune responses, and the fact that in vitro culture is an established technique, renders this parasite a very attractive model to study the host-parasite interplay in view to reveal potentially novel modes of therapy [56] . Increased concentrations of the pro-inflammatory cytokines TNF-a, IL-1b, iNOS and the anti-inflammatory IL-I0 are characteristic for secondary AE in mice [58] . With regard to the hepatic gene expression profiles of our study related to immunosuppressive pathways (thus potentially also to the support of parasite survival capacities), overexpressed molecules such as FGL2 can already interfere at early innate stage by inhibiting dendritic cell maturation, or by reducing T cell activation (VCAM-1). Such effects can be associated with enhanced parasite growth in the liver [64] . Interestingly, like in many other helminthic infections, the host immune response seems to make use of a rather Th2-dependent eosinophilic component to trigger its fight against the infectious agent (Ear2, EDN). The mobilization of eosinophils is known to be a crucial immunological event that plays an important role in the host defense against helminths. Despite appropriate host signals, there is a marked lack of eosinophilic infiltrates in experimental murine AE [59] . One possible explanation was recently provided by the demonstration that E. multilocularis metabolites exhibit proteolytic activity on eotaxin in vitro [58] . Inhibition of eotaxin activity may suppress the mobilization of eosinophils in E. multilocularis -infected mice. Absent eosinophils thus may be a part of a series of events that maintain a low level of inflammation in E. multilocularis -infected hosts. HEPATO-PATHOGENESIS The pathogenesis of liver damage in AE arises from the interplay of the parasitic metacestode and the host inflammatory response. It is generally accepted that the release of parasitic products/metabolites (such as cysteine proteases [59] ) into the periparasitic hepatic tissue triggers the inflammatory response in the liver parenchyma by inducing the production and release of inflammatory cytokines, chemokines and lipid inflammatory mediators [59] . At an early stage of infection, little liver damage is observed [65] . That may be the reason why our study yielded few deregulated genes related to hepatocyte functions. The upregulation of a lipoprotein lipase and a hexokinase most likely involved in anabolism and the downregulation of crotonase are indications for a metabolic reprogramming of hepatocytes ( Fig. 1 ) in the direction of fat accumulation (differentiation of adipocytes). Recently, an apolipoprotein binding protein from E. multilocularis hydatid fluid has been characterized [66] . These findings indicate the parasite may act as a sink for host lipids and stimulates lipid accumulation in vicinal host tissue. It is, however, unclear whether E. multilocularis is able to use lipids as a source for carbon and energy. Although it is clear that glycolysis and tricarboxylic acid cycle are functional (yielding succinate under anaerobic conditions), results concerning lipid catabolism via beta-oxidation are lacking [67] . Host lipids may also be attracted and exposed as a part of a strategy to circumvent the host immune system. In any case, these proteins could be interesting targets to address in future studies, presently these molecules remain still at a speculative level and are difficult to discuss without further pathological characteristics related to these molecules. At a late stage of infection, fibrosis becomes a hallmark of AE, leading to a complete disappearance of the liver parenchyma and even to the death of the metacestode, with vesicles embedded in an acellular tissue composed nearly entirely of cross-linked collagens [68] . The diffusion of the fibrotic process even far from the parasitic lesions strongly suggests a major role for cytokines in collagen synthesis. But these features could not be addressed and thus also not discussed in the present study. As mentioned above, we will design new studies respecting temporal aspects to unravel late stage characteristics of murine AE. CONCLUSION The conventional course of AE as a disease in humans resembles strongly that of the naturally infected mouse, in that untreated AE will, in many but not most cases, finally lead to fatality. In order to better understand periparasitic events characterizing the host response to infection, we assessed the gene expression profile in the periparasitic liver tissue during early chronic AE. High throughput analysis of gene expression yielded a set of mostly immunologically related upregulated genes, while downregulation almost exclusively lacked. The data presented herein may provide a road map for further investigations into the pathophysiology of AE and may help to identify potential targets for adjuvant therapy of this disease. Future interest will also focus on unraveling similar events but at late stage infection. METHODS An established mouse model of primary alveolar echinococcosis was used as previously described [3] , [69] . The animal studies were approved by the Animal Care and Experimentation Committee of the Canton of Bern, Switzerland, and followed National Institutes of Health guidelines for the performance of animal experiments. Briefly, 8-weeks-old female C57BL6/J mice were purchased from Charles River GmbH (Germany), and infected (n = 10) at the age of 10 weeks by peroral inoculation with 100 µl sterile water containing 2×10 3 eggs of E. multilocularis , using appropriate biosafety level 3 laboratory conditions (Swiss biosafety approval number A990006/3A). The infecting organisms (parasite eggs) were initially isolated from a naturally infected fox. Egg viability and infectiosity were pre-evaluated upon explorative titrated infection experiments carried out in mice preliminarily to the present studies [4] . Mock-infected control animals (n = 5) were perorally inoculated with 100 µl of sterile water. 31 days after infection, the animals were weighed and the infection intensity of AE was scored by counting the number of parasitic lesions macroscopically visible on and within the liver tissue [4] . Animals were sacrificed with an overdose of pentobarbital (100 mg/kg, intraperitoneally) for the mock-infected control group (n = 5) and for the group representing the chronic stage of primary AE (n = 10). TISSUE PROCESSING Animals were perfused via the left cardiac ventricle with 30 ml of ice-cold, RNase-free phosphate buffered saline (PBS) followed by 30 ml of 50% RNAlater@ (Ambion Europe Ltd., Huntingdon, UK) in ice-cold, RNase-free PBS. Immediately afterwards, the liver was removed. Approximately 5 mm 3 –sized periparasitic liver tissue blocks (adjacent by 1 mm to the macroscopically visible parasitc lesion) were dissected and stored separately in 150 µl of RNAlater® at 4°C until isolation of RNA. RNA PROCESSING AND MICROARRAY HYBRIDIZATION Liver tissue samples of each animal were processed and analyzed separately. Total RNA was extracted from liver tissue using RNeasy® Lipid Tissue kit (QIAGEN, Basel, Switzerland) and purified with RNeasy columns (QIAGEN, Basel, Switzerland). Quantification and assessment of RNA integrity were performed on the Agilent 2100 bioanalyzer platform (RNA 6000 Nano, Agilent technologies, Waldbronn, GER) and validated on the NanoDrop® (NanoDrop, Wilmington, USA) quantification device. Based on RNA quality control results and histopathological evaluation of hippocampal damage (apoptosis score) RNA extracts from 3 infected and 3 control animals were selected for each time point for array hybridization. Double-stranded cDNAs were synthesized from 5 µg of total RNA using an oligo dT-T7 promoter primer (Roche Molecular Biochemicals, Mannheim, Germany). The cDNAs obtained were used as templates for in vitro transcription using the Megascript kit purchased from Ambion (Austin, TX) and biotinylated nucleotides (Bio-11-CTP and Bio-16-UTP) provided by Roche Molecular Biochemicals (Basel, Switzerland). Fragmented in vitro transcripts (cRNAs) were hybridized overnight on to commercially available rat microarrays (GeneChip® Rat Genome 230 2.0 Array, Affymetrix, Santa Clara, CA) containing 31'000 probe sets representing approximately 28'000 well-substantiated rat genes. The hybridized samples were stained with streptavidin-R phycoerythrin (SAPE, Molecular Probes Inc., Eugene, OR) and the signal was amplified using a biotinylated goat anti-streptavidin antibody (Vector Laboratories, Burlingame, CA). Washing, staining and amplification were carried out in an Affymetrix GeneChip® Fluidics Station 450. Microarrays were scanned in an Affymetrix GeneChip® scanner 3000. Signal intensities were calculated based on image files with the Affymetrix GeneChip® Operating software (GCOS) v1.1.1. RAW DATA ANALYSIS Chip data analysis was performed on the R platform for statistical programming using packages of the Bioconductor project [70] . Due to the asymmetric distribution of microarray data all datasets were log2 transformed. Background correction, normalization and data summary were performed with non linear methods using the rma function of the affy package [71] . Chip quality assessment was exploratively performed based on boxplots of the raw log scale intensities and MA-plots visualizing signal intensity dependent effects on the log-ratios. Additionally the quality of the hybridized cRNA was assessed by RNA digestion plots where the mean intensities of all probes on an array are plotted according to their 5′ to 3′probeset position (affy package). To reduce the number of hypothesis to be tested in the subsequent significant tests, genefiltering was perfomed. All genes that were expressed under the estimated background intensity of 60 fluorescent units (FU) on at least 4 of the 8 chips and genes showing an interquantile range (IRQ) of less than 0.5 were excluded from significance testing. Significance testing was performed using the limma package [72] . Type 1 error was corrected by the Benjamini-Hochberg false discovery rate algorithm [73] . All raw data is MIAME compliant and have been deposited in “ArrayExpress” (EMBL/EBI) (accession no. E-MEXP-2615). CUSTOM-DESIGNED TAQMAN® GENE EXPRESSION ASSAYS In order to obtain an ex vivo confirmation of the Affymetrix gene expression findings, we selected 18 (upregulated) out of the 36 genes initially differentially expressed, to subject them to a custom-designed real-time PCR Applied Biosystems 7900HT Micro Fluidic Card system. For this, TaqMan Low Density Arrays using 384-well micro fluidic cards were pre-loaded with a selection ( Table 3 ) of differentially expressed genes (selection was primarily based upon the availability of standardized primer pairs to quantitatively investigate respective gene expression). Relative quantification was based on the reference of the following 5 constitutively expressed reference genes ( Table 4 ). These genes were selected from the microarray data based on i) their minimal variability between the control and infection group ii) their absolute expression level covering the whole array signal range. TABLE: Selected list of genes and respective primer sets to assess expression status at the mRNA level using a TaqMan® Custom Array microfluidic card system. # gene description Applied Biosystems primer sets 01 T-cell specific GTPase Tgtp-Mm00786926_s1 03 histocompatibility 2, class II antigen A, beta 1 H2-Ab1-Mm00439216_m1 04 histocompatibility 2, class II antigen E beta H2-Eb1-Mm00439221_m1 07 histocompatibility 2, class II antigen A, alpha H2-Aa-Mm00439211_m1 08 chemokine (C-X-C motif) ligand 9 Cxcl9-Mm00434946_m1 09 chemokine (C-C motif) ligand 5 Ccl5-Mm01302427_m1 10 chemokine (C-X-C motif) ligand 10 Cxcl10-Mm00445235_m1 13 macrophage receptor with collagenous structure Marco-Mm00440265_m1 16 CD74 antigen (invariant polypeptide of MHC class II) Cd74-Mm00658576_m1 19 lymphocyte antigen 86 Ly86-Mm00440240_m1 20 vascular cell adhesion molecule 1 Vcam1-Mm00449197_m1 21 membrane-spanning 4-domains, subfamily A, member 4B Ms4a4b-Mm00649916_m1 24 fibrinogen-like protein 2 Fgl2-Mm00433327_m1 25 signal transducer and activator of transcription 1 Stat1-Mm00439518_m1 30 lipoprotein lipase Lpl-Mm00434764_m1 31 lectin, galactose binding, soluble 3 Lgals3-Mm00802901_m1 36 C-type lectin domain family 7, member a Clec7a-Mm00490960_m1 38 RIKEN cDNA 1810022C23 gene 18S-Hs99999901_s1 TABLE: The custom-designed TaqMan® Gene Expression Assays were quantified upon use of 5 constitutively expressed reference genes and corresponding primer sets, respectively. gene description gene Applied Biosystems primer sets Glyceraldehyde-3-Phosphate Dehydrogenase GAPDH Gapdh-Mm99999915_g1 Mitochondrial resident protein ES1 ES-1 Es1-Mm00468347_m1 Ribosomal protein 23 RPL-23 Rpl23-Mm00787512_s1 Malate dehydrogenase 1 MDH1 Mdh1-Mm00485106_m1 Ribosomal protein 37 RPL-37 Rpl37-Mm00782745_s1 REFERENCES [1] Gottstein B Piarroux R 2008 Current trends in tissue-affecting helminths. Parasite 15 291 298 [2] Gottstein B Reichen J 2009 Echinococcosis/Hydatidosis. chapter 86 1549 1568 In: Manson's Tropical Diseases, 22 nd edition, eds. GC Cook and AI Zumla, Saunders Elsevier Ltd. [3] Siles-Lucas M Merli M Mackenstedt U Gottstein B 2003 The Echinococcus multilocularis 14-3-3 protein protects mice against primary but not secondary alveolar echinococcosis. Vaccine 21: 431–439. Parasite Immunol 20 623 629 [4] Gauci C Merli M Muller V Chow C Yagi K 2002 Molecular cloning of a vaccine antigen against infection with the larval stage of Echinococcus multilocularis . Infect Immun 70 3969 3972 [5] Bauder B Auer H Schilcher F Gabler C Romig T 1999 Experimental investigations on the B and T cell immune response in primary alveolar echinococcosis. Parasite Immunol 21 409 421 [6] Zhao Y Ferguson DJ Wilson DC Howard JC Sibley LD 2009 Virulent Toxoplasma gondi i evade immunity-related GTPase-mediated parasite vacuole disruption within primed macrophages. J Immunol 182 3775 3781 [7] Weinländer K Naschberger E Lehmann MH Tripal P Paster W 2008 Guanylate binding protein-1 inhibits spreading and migration of endothelial cells through induction of integrin alpha4 expression. FASEB J 22 4168 4178 [8] Degrandi D Konermann C Beuter-Gunia C Kresse A Würthner J 2007 Extensive characterization of IFN-induced GTPases mGBP1 to mGBP10 involved in host defense. J Immunol 179 7729 7740 [9] Schnoor M Betanzos A Weber DA Parkos CA 2009 Guanylate-binding protein-1 is expressed at tight junctions of intestinal epithelial cells in response to interferon-gamma and regulates barrier function through effects on apoptosis. Mucosal Immunol 2 33 42 [10] Brännström A Sankala M Tryggvason K Pikkarainen T 2002 Arginine residues in domain V have a central role for bacteria-binding activity of macrophage scavenger receptor MARCO. Biochem Biophys Res Commun 290 1462 1469 [11] Bandyopadhyay SK de la Motte CA Kessler SP Hascall VC Hill DR 2008 Hyaluronan-mediated leukocyte adhesion and dextran sulfate sodium-induced colitis are attenuated in the absence of signal transducer and activator of transcription 1. Am J Pathol 173 1361 1368 [12] Neufert C Becker C Wirtz S Fantini MC Weigmann B 2007 IL-27 controls the development of inducible regulatory T cells and Th17 cells via differential effects on STAT1. Eur J Immunol 37 1809 1816 [13] Ramsauer K Farlik M Zupkovitz G Seiser C Kröger A 2007 Distinct modes of action applied by transcription factors STAT1 and IRF1 to initiate transcription of the IFN-gamma-inducible gbp2 gene. Proc Natl Acad Sci U S A 104 2849 2854 [14] Jeong WI Park O Radaeva S Gao B 2006 STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity. Hepatology 44 1441 1451 [15] Shuai K 2000 Modulation of STAT signaling by STAT-interacting proteins. Oncogene 19 2638 2644 [16] Ramsey C Rubinstein MP Kim DM Cho JH Sprent J 2008 The lymphopenic environment of CD132 (common gamma-chain)-deficient hosts elicits rapid homeostatic proliferation of naive T cells via IL-15. J Immunol 180 5320 5326 [17] Xiao H Yin T Wang XY Uchida T Chung J 2002 Specificity of interleukin-2 receptor gamma chain superfamily cytokines is mediated by insulin receptor substrate-dependent pathway. J Biol Chem 277 8091 8098 [18] Hawkins PT Stephens LR 2007 PI3Kgamma is a key regulator of inflammatory responses and cardiovascular homeostasis. Science 318 64 66 [19] MacKinnon AC Farnworth SL Hodkinson PS Henderson NC Atkinson KM 2008 Regulation of alternative macrophage activation by galectin-3. J Immunol 180 2650 2658 [20] Gantner BN Simmons RM Canavera SJ Akira S Underhill DM 2003 Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J Exp Med 197 1107 1117 [21] Liu N Wang Y Ashton-Rickardt PG 2004 Serine protease inhibitor 2A inhibits caspase-independent cell death. FEBS Lett 569 49 53 [22] Faure-André G Vargas P Yuseff MI Heuzé M Diaz J 2008 Regulation of dendritic cell migration by CD74, the MHC class II-associated invariant chain. Science 322 1705 1710 [23] Manicone AM Burkhart KM Lu B Clark JG 2008 CXCR3 ligands contribute to Th1-induced inflammation but not to homing of Th1 cells into the lung. Exp Lung Res 34 391 407 [24] Zhai Y Shen XD Gao F Zhao A Freitas MC 2008 CXCL10 regulates liver innate immune response against ischemia and reperfusion injury. Hepatology 47 207 214 [25] Nakamichi K Inoue S Takasaki T Morimoto K Kurane I 2004 Rabies virus stimulates nitric oxide production and CXC chemokine ligand 10 expression in macrophages through activation of extracellular signal-regulated kinases 1 and 2. J Virol 78 9376 9388 [26] Koniaris LG Zimmers-Koniaris T Hsiao EC Chavin K Sitzmann JV 2001 Cytokine-responsive gene-2/IFN-inducible protein-10 expression in multiple models of liver and bile duct injury suggests a role in tissue regeneration. J Immunol 167 399 406 [27] Santiago HC Oliveira CF Santiago L Ferraz FO de Souza DG 2004 Involvement of the chemokine RANTES (CCL5) in resistance to experimental infection with Leishmania major . Infect Immun 72 4918 4923 [28] Xu H Williams MS Spain LM 2006 Patterns of expression, membrane localization, and effects of ectopic expression suggest a function for MS4a4B, a CD20 homolog in Th1 T cells. Blood 107 2400 2408 [29] Fujiwara K Daido S Yamamoto A Kobayashi R Yokoyama T 2008 Pivotal role of the cyclin-dependent kinase inhibitor p21WAF1/CIP1 in apoptosis and autophagy. J Biol Chem 283 388 397 [30] Hui L Zatloukal K Scheuch H Stepniak E Wagner EF 2008 Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation. J Clin Invest 118 3943 3953 [31] Asefa B Dermott JM Kaldis P Stefanisko K Garfinkel DJ 2006 p205, a potential tumor suppressor, inhibits cell proliferation via multiple pathways of cell cycle regulation. FEBS Lett 580 1205 1214 [32] Nagai Y Shimazu R Ogata H Akashi S Sudo K 2002 Requirement for MD-1 in cell surface expression of RP105/CD180 and B-cell responsiveness to lipopolysaccharide. Blood 99 1699 1705 [33] Shalev I Wong KM Foerster K Zhu Y Chan C 2009 The novel CD4+CD25+ regulatory T cell effector molecule fibrinogen-like protein 2 contributes to the outcome of murine fulminant viral hepatitis. Hepatology 49 387 397 [34] Liu H Shalev I Manuel J He W Leung E 2008 The FGL2-FcgammaRIIB pathway: a novel mechanism leading to immunosuppression. Eur J Immunol 38 3114 3126 [35] Stanley AC Dalton JE Rossotti SH MacDonald KP Zhou Y 2008 VCAM-1 and VLA-4 modulate dendritic cell IL-12p40 production in experimental visceral leishmaniasis. PLoS Pathog 19 4(9) e1000158 [36] Bansal G Druey KM Xie Z 2007 R4 RGS proteins: regulation of G-protein signaling and beyond. Pharmacol Ther 116 473 495 [37] Yang D Chen Q Su SB Zhang P Kurosaka K 2008 Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88 signal pathway in dendritic cells and enhances Th2 immune responses. J Exp Med 205 79 90 [38] Nakajima M Hirakata M Nittoh T Ishihara K Ohuchi K 2001 Expression and purification of recombinant rat eosinophil-associated ribonucleases, homologues of human eosinophil cationic protein and eosinophil-derived neurotoxin, and their characterization. Int Arch Allergy Immunol 125 241 249 [39] Yang D Rosenberg HF Chen Q Dyer KD Kurosaka K 2003 Eosinophil-derived neurotoxin (EDN), an antimicrobial protein with chemotactic activities for dendritic cells. Blood 102 3396 3403 [40] Mead JR Irvine SA Ramji DP 2002 Lipoprotein lipase: structure, function, regulation, and role in disease. J Mol Med 80 753 769 [41] Wilson JE 2003 Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function. J Exp Biol 206 2049 2057 [42] Fujii C Nakamoto Y Lu P Tsuneyama K Popivanova BK 2005 Aberrant expression of serine/threonine kinase Pim-3 in hepatocellular carcinoma development and its role in the proliferation of human hepatoma cell lines. Int J Cancer 114 209 218 [43] Macdonald A Campbell DG Toth R McLauchlan H Hastie CJ 2006 Pim kinases phosphorylate multiple sites on Bad and promote 14-3-3 binding and dissociation from Bcl-XL. BMC Cell Biol 10 7 1 [44] Agnihotri G Liu HW 2003 Enoyl-CoA hydratase. reaction, mechanism, and inhibition. Bioorg Med Chem 11 9 20 [45] Bresson-Hadni S Liance M Meyer JP Houin R Bresson JL 1990 Cellular immunity in experimental Echinococcus multilocularis infection. II. Sequential and comparative phenotypic study of the periparasitic mononuclear cells in resistant and sensitive mice. Clin Exp Immunol 82 378 383 [46] Emery I Liance M Deriaud E Vuitton DA Houin R 1996 Characterization of T-cell immune responses of Echinococcus multilo cularis-infected C57BL/6J mice. Parasite Immunol 18 463 472 [47] Playford MC Kamiya M 1992 Immune respoflse to Echinococcus multilocularis infection in the mouse model. Jpn J Vet Res 40 113 130 [48] Playford MC Ooi HK Oku Y Kamiya M 1992 Secondary Echinococcus multilocularis infection in severe combined immunodeficient (scid) mice: biphasic growth of the larval cyst mass. Int J Parasitol 22 975 982 [49] Sailer M Soelder B Allerberger F Zaknun D Feichtinger H 1997 Alveolar echinococcosis of the liver in a six-year-old girl with acquired immunodeficiency syndrome. J Pediatr 130 320 323 [50] Zingg W Renner-Schneiter EC Pauli-Magnus C Renner EL van Overbeck J 2002 Alveolar echinococcosis of the liver in an adult with human immunodeficiency virus type-1 infection. Infection 32 299 302 [51] Liance M Aicard-Blum S Emery I Houin A Vuitton DA 1998 Echinococcus multilocularis infection in mice: in vivo treatment with a low dose of IFN-gamma decreases metacestode growth and liver fibrogenesis. Parasite 5 231 237 [52] Jenne L Kilwinski J Aadloff P Flick W Kern P 1998 Clinical efficacy of and immunologic alterations caused by interferon gamma therapy for alveolar echinococcosis. Clin Infect Dis 26 492 494 [53] Amiot F Vuong P Defontaines M Pater C Dautry F 1999 Secondary alveolar echinococcosis in Iymphotoxinalpha and tumour necrosis factor-alpha deficient mice: exacerbation of Echinococcus multilocularis larval growth is associated with cellular changes in the periparasitic granuloma. Parasite Immunol 21 475 483 [54] Godot V Harraga S Podoprigora G Liance M Bardonnet K 2003 IFN alpha-2a protects mice against a helminth infection of the liver and modulates immune responses. Gastroenterol 124 1441 1450 [55] Emery I Leclerc C Sengphommachanh K Vuitton DA Liance M 1998 In vivo treatment with recombinant IL-12 protects C57BL/6J mice against secondary alveolar echinococcosis. Parasite Immunol 20 81 91 [56] Vuitton DA 2003 The ambiguous role of immunity in echinococcosis: protection of the host or of the parasite? Acta Trop 85 119 132 [57] Dai WJ Waldvogel A Jungi T Stettler M Gottstein B 2003 Inducible nitric oxide synthase-deficiency in mice increases resistance to chronic infection with Echinococcus multilocularis . Immunol 10 238 244 [58] Mejri N Gottstein B 2006 Intraperitoneal Echinococcus multilocularis infection in C57BL/6 mice inhibits the up-regulation of B7-1 and B7-2 co-stimulator expression on peritoneal macrophages and causes failure to enhance peritoneal T cell activation. Parasite Immunol 28 373 385 [59] Mejri N Gottstein B 2009 Echinococcus multilocularis metacestode metabolites contain a cysteine protease that digests eotaxin, a CC pro-inflammatory chemokine. Parasitol Res, Jul 2 [Epub ahead of print] [60] Pennock JL Grencis RK 2006 The mast cell and gut nematodes: damage and defence. Chem Immunol Allergy 90 128 140 [61] Baron RW Tanner CE 1976 The effect of immunosuppression on secondary Echinococcus multilocularis infections in mice. Int J Parasitol 6 37 42 [62] Devouge M Ali-Khan Z 1983 Intraperitoneal murine alveolar hydatidosis: relationship between the size of the larval cyst mass, immigrant inflammatory cells, splenomegaly and thymus involution. Tropenmed Parasito! 34 15 20 [63] Kizaki T Ishige M Bingyan W Day NK Good RA 1993 Generation of CD8+ suppressor T cells by proto scoleces of Echinococcus multilocularis in vitro. Immunol 79 412 417 [64] Stanley AC Dalton JE Rossotti SH MacDonald KP Zhou Y 2008 VCAM-1 and VLA-4 modulate dendritic cell IL-12p40 production in experimental visceral leishmaniasis. PLoS Pathog 19 e1000158 [65] Vuitton DA Zhang SL Yang Y Godot V Beurton I 2006 Survival strategy of Echinococcus multilocularis in the human host. Parasitol 55 S51 S55 [66] Bernthaler P Epping K Schmitz G Deplazes P Brehm K 2009 Molecular characterization of EmABP, an apolipoprotein A-I binding protein secreted by the Echinococcus multilocularis metacestode. Infect Immun 77 5564 5571 [67] McManus DP 2009 Reflections on the biochemistry of Echinococcus : past, present and future. Parasitology 136 1643 1652 [68] Vuitton DA Guerret-Stocker S Carbillet JP Mantion G Miguet JP 1986 Collagen immunotyping of the hepatic fibrosis in human alveolar echinococcosis. Z Parasitenkd 72 97 104 [69] Pater C Müller V Harraga S Liance M Godot V 1998 Intestinal and systemic humoral immunological events in the susceptible Balb/C mouse strain after oral administration of Echinococcus multilocularis eggs. [70] Gentleman RC Carey VJ Bates DM Bolstad B Dettling M 2004 Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5 R80 [71] Gautier L Cope L Bolstad BM Irizarry RA 2004 Affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20 307 315 [72] Kooperberg C Aragaki A Strand AD Olson JM 2005 Significance testing for small microarray experiments. Stat Med 24 2281 2298 [73] Benjamini Y Drai D Elmer G Kafkafi N Golani I 2001 Controlling the false discovery rate in behavior genetics research. Behav Brain Res 125 279 284